Abstract

Type-C RNA viruses are believed to be etiologically associated with the vast majority of naturally occurring cancers of mouse (Gross, 1958; Huebner and Todaro, 1969). The viruses occur in vivo either spontaneously (Gross, 1953, 1958) or after exposure to radiation (Kaplan and Brown, 1952; Lieberman and Kaplan, 1959), chemical carcinogens (Igel et al., 1969; Huebner et al., 1971 a; Whitmire et al., 1971; Ball and McCarter, 1971), or biological substances and phenomena (Hellman and Fowler, 1971; Hirsch et al., 1972; Chen et al., 1972) in mice of diverse strains, including the high-leukemia-incidence inbred strains, such as the albino Ak and C58 black, low-leukemia-incidence, strains such as C57 black and C3H, and strains with intermediate incidence of leukemia, such as DBA/2 and BALB/c. Recent evidence suggests that most, if not all mice, regardless of sex, breed, or origin, contain viral genomes of mouse type-C RNA viruses in hidden or unexpressed forms, and that the virus can be activated both in vivo and in vitro by various induction techniques (Huebner and Todaro, 1969; Todaro and Huebner, 1972).

Keywords

Lymphoma Leukemia Sarcoma Polypeptide Myeloma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaroson, S.A.: Common genetic alterations of RNA tumor viruses grown in human cells. Nature (Lond.) 230, 445–447 (1971a).Google Scholar
  2. Aaronson, S. A.: Isolation of a rat-tropic helper virus from M-MSV-O stocks. Virology 44, 29–36 (1971b).PubMedGoogle Scholar
  3. Aaronson, S. A., Bassin, R. H., Weaver, C.: Comparison of murine sarcoma viruses in nonproducer and S+L—transformed cells. J. Virol. 9, 701–704 (1972).PubMedGoogle Scholar
  4. Aaronson, S. A., Hartley, J. W., Todaro, G. J.: Mouse leukemia virus: spontaneous release by mouse embryo cells after long term in vitro cultivation. Proc. nat. Acad. Sci. (Wash.) 64, 87–94 (1969).Google Scholar
  5. Aaronson, S. A., Jainchill, J. L., Todaro, G. J.: Murine sarcoma virus transformation of BALB/3T3 cells: lack of dependence on murine leukemia virus. Proc. nat. Acad. Sci. (Wash.) 66, 1236–1243 (1970).Google Scholar
  6. Aaronson, S. A., Parks, W. P., Scolnick, E. M., Todaro, G. J.: Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses. Proc. nat. Acad. Sci. (Wash.) 68, 920–924 (1971a).Google Scholar
  7. Aaronson, S. A., Rowe, W. P.: Nonproducer clones of murine sarcoma virus transformed BALB/3T3 cells. Virology 42, 9–19 (1970).PubMedGoogle Scholar
  8. Aaronson, S. A., Stephenson, J. R.: Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells. Proc. nat. Acad. Sci. (Wash.) 70, 2055–2058 (1973).Google Scholar
  9. Aaronson, S. A., Stephenson, J. R.: Widespread natural occurrence of high-titered neutralizing antibodies to a specific class of endogenous mouse type C virus. Proc. nat. Acad. Sci. (Wash.) In press (1974).Google Scholar
  10. Aaronson, S. A., Todaro, G. J., Scolnick, E. M.: Induction of murine C-type viruses from clonal lines of virus-free BALB/3T3 cells. Science 174, 157–159 (1971b).PubMedGoogle Scholar
  11. Aaronson, S. A., Weaver, C. A.: Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells. J. gen. Virol. 13, 245–252 (1971).PubMedGoogle Scholar
  12. Ablashi, D. V., Turner, W., Armstrong, G. R., Bass, L. R.: Characterization of murine Rauscher leukemia virus propagated in human cells. J. nat. Cancer Inst. 48, 615–621 (1972).PubMedGoogle Scholar
  13. Aoki, T.: Surface antigens of murine leukemia cells and murine leukemia viruses. Transplant. Proc. 111, 1195–1198 (1971).Google Scholar
  14. Aoki, T., Boyse, E. A., Old, L. J.: Occurrence of natural antibody to the G (Gross) leukemia antigen in mice. Cancer Res. 26, 1415–1419 (1966).PubMedGoogle Scholar
  15. Aoki, T., Boyse, E. A., Old, L. J.: Wildtype Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice. J. nat. Cancer Inst. 41, 89–96 (1968).PubMedGoogle Scholar
  16. Aoki, T., Boyse, E. A., Old, L. J., de Harven, E., Hammerling, U., Wood, H. A.: G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labelled antibody. Proc. nat. Acad. Sci. (Wash.) 65, 569–576 (1970).Google Scholar
  17. Aoki, T., Herberman, R. B., Johnson, P. A., Liu, M., Sturm, M. M.: Wild-type Gross leukemia virus: classification of soluble antigens (GSA). J. Virol. 10, 1208–1219 (1972).PubMedGoogle Scholar
  18. Aoki, T., Stephenson, J. R., Aaronson, S. A.: Demonstration of a cell-surface antigen associated with Murine sarcoma virus by immunoelectron microscopy. Proc. nat. Acad. Sci. (Wash.) 70, 742–748 (1973).Google Scholar
  19. Aoki, T., Takahashi, T.: Viral and cellular surface antigens of murine leukemias and myelomas. J. exp. Med. 135, 443–457 (1972).PubMedGoogle Scholar
  20. Aoki, T., Todaro, G. J.: Antigenic Properties of endogenous type-C viruses from spontaneously transformed clones of BALB/3T3. Proc. nat. Acad. Sci. (Wash.) 70, 1598–1602 (1973).Google Scholar
  21. Ball, J. K., McCarter, J. A.: Repeated demonstration of a mouse leukemia virus after treatment with chemical carcinogens. J. nat. Cancer Inst. 46, 751–762 (1971).PubMedGoogle Scholar
  22. Ball, J. K., McCarter, J. A., Sunderland, S. M.: Evidence for helper independent murine sarcoma virus. I. Segregation of replication-defective and transformation-defective viruses. Virology 56, 268–284 (1973).PubMedGoogle Scholar
  23. Baltimore, D.: RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature (Lond.) 226, 1209–1211 (1970).Google Scholar
  24. Bass, L. R., Turner, W.: Semi-micro XC cell assay technique for murine leukemia virus. Appl. Microbiol. 23, 201 (1972).Google Scholar
  25. Bassin, R. H., Phillips, L. A., Kramer, M. J., Haapala, D. K., Peebles, P. T., Nomura, S., Fischinger, P. J.: Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc. nat. Acad. Sci. (Wash.) 68, 1520–1524 (1971a).Google Scholar
  26. Bassin, R. H., Tuttle, N., Fischinger, P. J.: Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int. J. Cancer 6, 95–107 (1970).PubMedGoogle Scholar
  27. Bassin, R. H., Tuttle, N., Fischinger, P. J.: Rapid cell culture assay technique for murine leukaemia viruses. Nature (Lond.) 229, 564–566 (1971b).Google Scholar
  28. Bauer, H., Bubenek, J., Graf, T., Allgaier, C.: Induction of transplantation resistance to Rous sarcoma isograft by avian leukosis virus. Virology 39, 482–490 (1969).PubMedGoogle Scholar
  29. Benveniste, R. E., Lieber, M. M., Livingston, D. M., Sherr, C. J., Todaro, G. J., Kalter, S. S.: Infectious type C virus isolated from a baboon placenta. Nature (Lond.), in press (1974).Google Scholar
  30. Benveniste, R. E., Lieber, M. M., Todaro, G. J.: A distinct class of inducible murine type C viruses which replicate in the rabbit SIRC cell line. Proc. nat. Acad. Sci. (Wash.), in press (1973b).Google Scholar
  31. Benveniste, R. E., Todaro, G. J., Scolnick, E. M., Parks, W. P.: Partial transcription of murine type C viral genomes in BALB/c cell lines. J. Virol. 12, 711–720 (1973a).PubMedGoogle Scholar
  32. Bernard, C., Chuat, J. C., Laprevotte, I., Boiron, M.: Further studies on mouse sarcoma virus (Moloney) replication in human cells. Partial host range shift of progeny virus. Int. J. Cancer 10, 518–526 (1972).PubMedGoogle Scholar
  33. Chang, S. S., Gilden, R. V., Huebner, R. J.: Rescue of murine sarcoma virus genome in mixed cultures of ‘non-producer’ hamster tumour cells and helper virus carrier cell lines. J. gen. Virol. 10, 107–110 (1971).PubMedGoogle Scholar
  34. Chen, H. W., Meier, H., Heiniger, H. J., Huebner, R. J.: Tumorigenesis in Strain DW/J mice and induction by prolactin of the group-specific antigen of endogenous C-type RNA tumor virus. J. nat. Cancer Inst. 49, 1145–1154 (1972).PubMedGoogle Scholar
  35. Chuat, J. C., Bernard, C., Lasquellec, F., Tchen, P., Boiron, M.: Studies on murine sarcoma virus: III. Synthesis of the viral antigens in cells of various species. Proc. Soc. exp. Biol. (N.Y.) 139, 1071–1077 (1972).Google Scholar
  36. Chuat, J. C., Lasquellex, F., L’Hirondel, A. M., Boiron, M.: Studies on murine sarcoma virus: II. Detection of group-specific antigens by immunofluorescence. Int. J. Cancer 7, 101–111 (1971).PubMedGoogle Scholar
  37. Duh, F. G., Vernon, M. L., Rhim, J. S.: In vitro transformation of canine embryo cells by murine sarcoma virus (Kirsten). Proc. Soc. exp. Biol. (N.Y.) 142, 1277–1280 (1973).Google Scholar
  38. Eckner, R. J., Steeves, R. A.: A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera. J. exp. Med. 136, 832–850 (1972).PubMedGoogle Scholar
  39. Finkel, M. P., Biskis, B. O., Jinkins, P. B.: Virus induction of osteosarcomas in mice. Science 151, 698–701 (1966).PubMedGoogle Scholar
  40. Fischinger, P. J., O’Connor, T. E.: Viral infection across species barriers: reversible alteration of murine sarcoma virus for growth in cat cells. Science 165, 714–716 (1969).PubMedGoogle Scholar
  41. Fischinger, P. J., Peebles, P. T., Nomura, S., Haapala, D. K.: Isolation of an RD-114-like oncornavirus from a cat cell line. J. Virol. 11, 978–985 (1973).PubMedGoogle Scholar
  42. Fischinger, P. J., Schäfer, W., Seifert, E.: Detection of some murine leukemia virus antigens in virus particles derived from 3T3 cells transformed only by murine sarcoma virus. Virology 47, 229–235 (1972).PubMedGoogle Scholar
  43. Gardner, M. B., Henderson, B. E., Officer, J. E., Rongey, R. W., Parker, J. C., Oliver, C., Estes, J. D., Huebner, J. R.: A spontaneous lower motor neuron disease apparently caused by indigenous type C virus in wild mice. J. nat. Cancer Inst. 51, 1243–1253 (1973 b).PubMedGoogle Scholar
  44. Gardner, M. B., Henderson, B. E., Rongey, R. W., Estes, J. D., Huebner, R. J.: Spontaneous tumors of aging wild house mice. Incidence, pathology, and C-type virus expression. J. nat. Cancer Inst. 50, 719–734 (1973a).PubMedGoogle Scholar
  45. Gardner, M. B., Officer, J. E., Rongey, R. W., Estes, J. D., Turner, H. C., Huebner, R. J.: C-type RNA tumour virus genome expression in wild house mice. Nature (Lond.) 232, 617–620 (1971).Google Scholar
  46. Gazdar, A. F., Chopra, H. C., Sarma, P. S.: Properties of a murine sarcoma virus isolated from a tumor arising in an NZW/NZB F1 hybrid mouse. I. Isolation and pathology of tumors induced in rodents. Int. J. Cancer 9, 219–233 (1972a).PubMedGoogle Scholar
  47. Gazdar, A., Hatanaka, M., Herberman, R., Russell, E., Ikawa, Y.: Effects of dibutyryl cyclic adenosine phosphate plus theophylline on murine sarcoma virus transformed non-producer cells. Proc. Soc. exp. Biol. (N.Y.) 141, 1044–1050 (1972c).Google Scholar
  48. Gazdar, A. F., Phillips, L. A., Sarma, P. S., Peebles, P. T., Chopra, H. C.: Presence of sarcoma genome in a ‘non-infectious’ mammalian virus. Nature (Lond.) New Biol. 234, 69–72 (1971).Google Scholar
  49. Gazdar, A. F., Russell, E., Sarma, P. S., Sarin, P. S., Hall, W., Chopra, H. C.: Properties of noninfectious and transforming viruses released by murine sarcoma virus-induced hamster tumor cells. J. Virol. 12, 931–936 (1973).PubMedGoogle Scholar
  50. Gazdar, A. F., Sarma, P. S., Bassin, R. H.: Properties of a murine sarcoma virus isolated from a tumor arising in an NZW/NZB F1 hybrid mouse. II. Physical and biological characteristics. Int. J. Cancer 9, 234–241 (1972b).PubMedGoogle Scholar
  51. Geering, G., Aoki, T., Old, L. J.: Shared viral antigen of mammalian leukaemia viruses. Nature (Lond.) 226, 265–266 (1970).Google Scholar
  52. Geering, G., Old, L. J., Boyse, E. A.: Antigens of leukemias induced by naturally occurring murine leukemia viruses: their relation to the antigens of Gross virus and other murine leukemia viruses. J. exp. Med. 124, 753–772 (1966).PubMedGoogle Scholar
  53. Gelb, L. D., Aaronson, S. A., Martin, M. A.: Heterogeneity of murine leukemia virus in vitro DNA; detection of viral DNA in mammalian cells. Science 172, 1353–1355 (1971).PubMedGoogle Scholar
  54. Gelb, L. D., Milstien, J. B., Martin, M. A., Aaronson, S. A.: Characterization of murine leukaemia virus-specific DNA present in normal mouse cells. Nature (Lond.) New Biol. 244, 76–79 (1973).Google Scholar
  55. Gilden, R. V., Lee, Y. K., Long, C.: Rescue of the murine sarcoma virus genome from non-producer cells by the RD-114 type C virus. Int. J.Cancer 10, 458–462 (1972).PubMedGoogle Scholar
  56. Gilden, R. V., Oroszlan, S.: Group-specific antigens of RNA tumor viruses as markers for subinfectious expression of the RNA virus genome. Proc. nat. Acad. Sci. (Wash.) 69, 1021–1025 (1972).Google Scholar
  57. Gilden, R. V., Oroszlan, S., Huebner, R. J.: Coexistence of intraspecies and interspecies specific antigenic determinants on the major structural polypeptide of mammalian C-type viruses. Nature (Lond.) New Biol. 231, 107–108 (1971).Google Scholar
  58. Girardi, A., Hampar, B., Hsu, K. C., Oroszlan, S., Hornberger, E., Kelloff, G., Gilden, R. V.: Intracellular localization of mammalian type C virus species-specific (gs-1) and interspecies-specific (gs-3) antigenic determinants using the indirect immunoperoxidase technique and light microscopy. J. Immunol. 111, 152–156 (1973).PubMedGoogle Scholar
  59. Glynn, J. P., McCoy, J. L., Fefer, A.: Cross-resistance to the transplantation of syngeneic Friend, Moloney and Rauscher virus-induced tumors. Cancer Res. 28, 434–439 (1968).PubMedGoogle Scholar
  60. Gomard, E., Leclerc, J. C., Levy, J. P.: Murine leukemia and sarcoma viruses: Further studies on the antigens of the viral envelope. J. nat. Cancer Inst. 50, 955–961 (1973).PubMedGoogle Scholar
  61. Green, M., Rokutanda, H., Rokutanda, M.: Virus-specific RNA in cells transformed by RNA tumor viruses. Nature (Lond.) New Biol. 230, 229–232 (1971).Google Scholar
  62. Gregoriades, A., Old, L. J.: Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses. Virology 37, 189–202 (1969).PubMedGoogle Scholar
  63. Gross, L.: Pathogenic properties, and “vertical” transmission of the mouse leukemia agent. Proc. Soc. exp. Biol. (N.Y.) 78, 342–348 (1951).Google Scholar
  64. Gross, L.: Presence of leukemia agent in normal testes and ovaries of young mice of AK line. Acta haemat. (Basel) 10, 18 (1953).Google Scholar
  65. Gross, L.: Viral etiology of “spontaneous” mouse leukemia: a review. Cancer Res. 18, 371 (1958).PubMedGoogle Scholar
  66. Hampar, B., Gilden, R. V., Kelloff, G., Oroszlan, S., Simms, D.: Immunofluorescent detection of murine and hamster C-type virus species-specific (gs-1) determinants by monospecific guinea-pig sera and interspecies-specific (gs-3) determinants by tumor-bearing rat sera. Int. J. Cancer 8, 425–431 (1971).PubMedGoogle Scholar
  67. Hanna, M. G., Tennant, R. W., Yuhas, J. M., Clapp, N. K., Batzing, B. L., Snodgrass, M. J.: Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma. Cancer Res. 32, 2226–2234 (1972).PubMedGoogle Scholar
  68. Hartley, J. W.: Personal communication (1973).Google Scholar
  69. Hartley, J. W., Rowe, W. P.: Production of altered cell foci in tissue culture by defective Moloney sarcoma virus particles. Proc. nat. Acad. Sci. (Wash.) 55, 780–786 (1966).Google Scholar
  70. Hartley, J. W., Rowe, W. P., Capp, W. I., Huebner, R. J.: Complement fixation and tissue culture assays for mouse leukemia viruses. Proc. nat. Acad. Sci. (Wash.) 53, 931–938 (1965).Google Scholar
  71. Hartley, J. W., Rowe, W. P., Capps, W. I., Huebner, R. J.: Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture. J. Virol. 3, 126–132 (1969).PubMedGoogle Scholar
  72. Hartley, J. W., Rowe, W. P., Huebner, R. J.: Host range restriction of murine leukemia viruses in mouse embryo cell cultures. J. Virol. 5, 221–225 (1970).PubMedGoogle Scholar
  73. Harvey, J. J.: An unidentified virus which causes the rapid production of tumours in mice. Nature (Lond.) 204, 1104–1105 (1964).Google Scholar
  74. Hellman, A., Fowler, A. K.: Hormone-activated expression of the C-type RNA tumour virus genome. Nature (Lond.) New Biol. 233, 142–144 (1971).Google Scholar
  75. Hilgers, J., Nowinski, R. C., Geering, G., Hardy, W.: Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res. 32, 98–106 (1972).PubMedGoogle Scholar
  76. Hino, S., Yamaguchi, N., Yamamoto, T.: Characteristics of a virus found in a Rous mouse cell line. SR-C3H-2127. Jap. J. exp. Med. 42, 43–52 (1972).PubMedGoogle Scholar
  77. Hirsch, M. S., Allison, A. C., Harvey, J. J.: Immune complexes in mice infected neonatally with Moloney leukemogenic and murine sarcoma viruses. Nature (Lond.) 223, 739–740 (1969).Google Scholar
  78. Hirsch, M. S., Phillips, S. M., Scolnik, C., Black, P. H., Schwartz, R. S., Carpenter, C. B.: Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc. nat. Acad. Sci. (Wash.) 69, 1069–1072 (1972).Google Scholar
  79. Huang, A. S., Besmer, P., Chu, L., Baltimore, D.: Growth of pseudotypes of vesicular stomatitis virus with n-tropic murine leukemia virus coats in cells resistant to n-tropic viruses. J. Virol. 12, 659–662 (1973).PubMedGoogle Scholar
  80. Huebner, R. J.: Antigens of the leukemia-sarcoma virus complexes. In: Proceedings of Perspectives in Leukemia, p. 123–132. New Orleans: Grune & Stratton, Inc. 1968.Google Scholar
  81. Huebner, R. J., Freeman, A. E., Whitmire, C. E., Price, P. J., Rhim, J. S., Kelloff, G. J., Gilden, R. V., Meier, H.: Endogenous and exogenous RNA tumor virus genome in chemical carcinogenesis. In: Environment and Cancer, a collection of papers presented at the 24th Ann. Symp. on Fund. Cancer Res. 318–345 (1971a).Google Scholar
  82. Huebner, R. J., Hartley, J. W., Rowe, W. P., Lane, W. T., Capps, W. I.: Rescue of the defective genome of Moloney sarcoma virus from a noninfectious hamster tumor and the production of pseudotype sarcoma viruses with various murine leukemia viruses. Proc. nat. Acad. Sci. (Wash.) 56, 1164–1169 (1966).Google Scholar
  83. Huebner, R. J., Kelloff, G. J., Sarma, P. S., Lane, W. T., Turner, H. C., Gilden, R. V., Oroszlan, S., Meier, H., Myers, D. D., Peters, R. L.: Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis. Proc. nat. Acad. Sci. (Wash.) 67, 366–376 (1970b).Google Scholar
  84. Huebner, R. J., Sarma, P. S., Kelloff, G. J., Gilden, R. V., Meier, H., Myers, D. D., Peters, R. L.: Immunological tolerance to RNA tumor virus genome expressions: significance of tolerance and prenatal expression in embryogenesis and tumorigenesis. Ann. N.Y. Acad. Sci. 181, 246–271 (1971b).Google Scholar
  85. Huebner, R. J., Todaro, G. J.: Oncogenes of RNA tumor viruses as determinants of cancer. Proc. nat. Acad. Sci. (Wash.) 64, 1087–1094 (1969).Google Scholar
  86. Huebner, R. J., Todaro, G. J., Sarma, P., Hartley, J. W., Freeman, A. E., Peters, R. L., Whitmire, C. E., Meier, H., Gilden, R. V.: “Switched off” vertically transmitted C-type RNA tumor viruses as determinants of spontaneous and induced cancer: a new hypothesis of viral carcinogenesis. In: Defectiveness, rescue, and stimulation of oncogenic viruses. 2nd International Symposium on Tumor Viruses, p. 33–57. Paris: Editions du Centre National de la Recherche Scientifique 1970a.Google Scholar
  87. Igel, H., Huebner, R. J., Turner, H. C., Kotin, P., Falk, H. L.: Mouse leukemia virus activation by chemical carcinogens. Science 166, 1624–1626 (1969).PubMedGoogle Scholar
  88. Ihle, J. N., Yurconic, M., Hanna, M. G.: Autogenous immunity to endogenous RNA tumor virus: Radioimmune precipitation assay of mouse serum antibody levels. J. exp. Med. 138, 194–208 (1973).PubMedGoogle Scholar
  89. Ikeda, H., Stockert, E., Rowe, W. P., Boyse, E. A., Lilly, F., Sato, H., Jacobs, S., Old, L. J.: Relation of chromosome 4 (linkage group VIII) to murine leukemia virus-associated antigens of AKR mice. J. exp. Med. 137, 1103–1108 (1973).PubMedGoogle Scholar
  90. Irino, S., Ota, Z., Sezaki, T., Suzaki, M., Hiraki, K.: Cell-free transmission of 20-methylcholanthrene-induced RF mouse leukemia and electron microscopic demonstration of virus particles in its leukemic tissue. Gann 54, 225–237 (1963).PubMedGoogle Scholar
  91. Jonsson, N., Sjogren, H. O.: Further studies on specific transplantation antigens in Rous sarcoma of mice. J. exp. Med. 122, 403–421 (1965).PubMedGoogle Scholar
  92. Kajima, M., Pollard, M.: Wide distribution of leukaemia virus in strains of laboratory mice. Nature (Lond.) 218, 188–189 (1968).Google Scholar
  93. Kaplan, H. S., Brown, M. B.: A quantitative dose-response study of lymphoid tumor development in irradiated C57 Black mice. J. nat. Cancer Inst. 13, 185 (1952).PubMedGoogle Scholar
  94. Kelloff, G., Huebner, R. J., Lee, Y. K., Toni, R., Gilden, R. V.: Hamster-tropic sarcomagenic and non-sarcomagenic viruses derived from hamster tumors induced by the Gross pseudotype of Moloney sarcoma virus. Proc. nat. Acad. Sci. (Wash.) 65, 310–317(1970).Google Scholar
  95. Kelloff, G. J., Hatanaka, M., Gilden, R. V.: Assay of C-type virus infectivity by measurement of RNA-dependent DNA polymerase activity. Virology 48, 266–269 (1972).PubMedGoogle Scholar
  96. Kirsten, W. H., Mayer, L. A.: Morphologic responses to a murine erythroblastosis virus. J. nat. Cancer Inst. 39, 311–335 (1971).Google Scholar
  97. Klement, V., Freedman, M. H., McAllister, R. M., Nelson-Rees, W. A., Huebner, R. J.: Differences in susceptibility of human cells to mouse sarcoma viruses. J. nat. Cancer Inst. 47, 65–73 (1971a).PubMedGoogle Scholar
  98. Klement, V., Nicolson, M. O., Huebner, R. J.: Rescue of the genome of focus forming virus from rat non-productive lines by 5-bromodeoxyuridine. Nature (Lond.) New Biol. 234, 12–14 (1971b).Google Scholar
  99. Klement, V., Rowe, W. P., Hartley, J. W., Pugh, W. E.: Mixed culture cytopatho-genicity: a new test for growth of murine leukemia viruses in tissue culture. Proc. nat. Acad. Sci. (Wash.) 63, 753–758 (1969).Google Scholar
  100. Krontiris, T. G., Soeiro, R., Fields, B. N.: Host restriction of Friend leukemia virus. Role of the viral outer coat. Proc. nat. Acad. Sci. (Wash.) 70, 2549–2553 (1973).Google Scholar
  101. Lerner, R. A., Jensen, F., Kennel, S. J., Dixon, F. J., Roches, G. D., Francke, U.: Karyotypic, virologie, and immunologic analyses of two continuous lymphocyte lines established from New Zealand black mice: possible relationship of chromosomal mosaicism to autoimmunity. Proc. nat. Acad. Sci. (Wash.) 69, 2965–2969 (1972).Google Scholar
  102. Levy, J. A.: Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains. Science 182, 1151–1153 (1973).PubMedGoogle Scholar
  103. Levy, J. A., Pincus, T.: Demonstration of biological activity of a murine leukemia virus of New Zealand black mice. Science 170, 326–327 (1970).PubMedGoogle Scholar
  104. Levy, J. A., Rowe, W. P.: Lack of requirement of murine leukemia virus for early steps in infection of mouse embryo cells by murine sarcoma virus. Virology 45, 844–847 (1971).PubMedGoogle Scholar
  105. Levy, J. P., Leclerc, J. C., Varet, B., Oppenheim, E.: Study of the antigenic specificity of Graffi leukemic cells. J. nat. Cancer Inst. 41, 743–750 (1968).PubMedGoogle Scholar
  106. Lieberman, M., Kaplan, H. S.: Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Science 130, 387–388 (1959).PubMedGoogle Scholar
  107. Lilly, F.: The inheritance of susceptibility to the Gross leukemia virus in mice. Genetics 53, 529–539 (1966).PubMedGoogle Scholar
  108. Lilly, F.: The effect of histocompatability-2 type on response to the Friend leukemia virus in mice. J. exp. Med. 127, 465–473 (1968).PubMedGoogle Scholar
  109. Lilly, F.: Mouse leukemia, a model of a multiple-gene disease. J. nat. Cancer Inst. 49, 927–934 (1972).PubMedGoogle Scholar
  110. Lilly, F., Pincus, T.: Genetic control of murine viral leukemogenesis. Advanc. Cancer Res. 17, 231–277 (1973).Google Scholar
  111. Livingston, D. M., Todaro, G. J.: Endogenous type C virus from a cat cell clone with properties distinct from previously described feline type C virus. Virology 53, 142–151 (1973).PubMedGoogle Scholar
  112. Lowy, D. R., Rowe, W. P., Teich, N., Hartley, J. W.: Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine. Science 174, 155–156 (1971).PubMedGoogle Scholar
  113. Mayyasi, S. A., Moloney, J. B.: Induced resistance of mice to a lymphoid strain of leukemia virus (Moloney). Cancer (Philad.) 20, 1124–1130 (1967).Google Scholar
  114. McDevitt, H. O., Deak, B. D., Shreffler, D. C., Klein, J., Stimpfling, J. H., Snell, G. D.: Genetic control of the immune response. Mapping of the Ir-1 locus. J. exp. Med. 135, 1259–1278 (1972).PubMedGoogle Scholar
  115. Meier, H., Myers, D. D., Huebner, R. J.: Genetic control by the hr-locus of susceptibility and resistance to leukemia. Proc. nat. Acad. Sci. (Wash.) 63, 759–766 (1969).Google Scholar
  116. Meier, H., Taylor, B. A., Cherry, M., Huebner, R. J.: Host-gene control of type-C RNA tumor virus expression and tumorigenesis in inbred mice. Proc. nat. Acad. Sci. (Wash.) 70, 1450–1455 (1973).Google Scholar
  117. Mellors, R. C., Shirai, T., Aoki, T., Huebner, R. J., Krawczynski, K.: Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J. exp. Med. 133, 113–132 (1971).PubMedGoogle Scholar
  118. Mizutani, S., Temin, H. M.: An RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Cold Spr. Harb. Symp. quant. Biol. 35, 847 (1971).Google Scholar
  119. Moloney, J.B.: A virus induced rhabdomyosarcoma of mice. Nat. Cancer Inst. Monogr. 22, 139 (1966).Google Scholar
  120. Naso, R. B., Vidrine, J. B., Wang, C. S., Arlinglaus, R. B.: C-type virus particles produced by normal mouse spleen-thymus cultures. Virology 47, 521–524 (1972).PubMedGoogle Scholar
  121. Nowinski, R. C., Fleissner, E., Sarkar, N. H., Aoki, T.: Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. J. Virol. 9, 359–366 (1972).PubMedGoogle Scholar
  122. Oda, T., Yamaguchi, N., Yamamoto, T.: Spontaneous production of murine type C virus particles by mouse Rous sarcoma cells after long-term in vitro cultivation. Gann 62, 535–538 (1971).PubMedGoogle Scholar
  123. Officer, J. E., Tecson, N., Estes, J. D., Fontanilla, E., Rongey, R. W., Gardner, M. B.: Isolation of a neurotropic type C virus. Science 181, 945–947 (1973).PubMedGoogle Scholar
  124. Old, L. J., Boyse, E. A.: Current enigmas in Cancer Research. Harvey Lect. 67, 273–315 (1972).Google Scholar
  125. Old, J., Boyse, E. A., Stockert, E.: Typing of mouse leukaemias by serological methods. Nature (Lond.) 201, 777–779 (1964).Google Scholar
  126. Old, L. J., Boyse, E. A., Stockert, E.: The G (Gross) leukemia antigen. Cancer Res. 25, 813–819 (1965).PubMedGoogle Scholar
  127. Oldstone, M. B. A., Aoki, T., Dixon, F. J.: Activation spontaneous murine leukemia virus-related antigen by lymphocytic choriomeningitis virus. Science 174, 843–845 (1971).PubMedGoogle Scholar
  128. Oldstone, M. B. A., Aoki, T., Dixon, F. J.: The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance. Proc. nat. Acad. Sci. (Wash.) 69, 134–138 (1972).Google Scholar
  129. Oroszlan, S., Fisher, C. L., Stanley, T. B., Gilden, R. V.: Proteins of the murine C-type RNA tumour viruses: isolation of a group-specific antigen by isoelectric focusing. J. gen. Virol. 8, 1–10 (1970).PubMedGoogle Scholar
  130. Oroszlan, S., Foreman, C., Kelloff, G., Gilden, R. V.: The group-specific antigen and other structural proteins of hamster and mouse C-type viruses. Virology 43, 665–674 (1971a).PubMedGoogle Scholar
  131. Oroszlan, S., Gilden, R. V.: Immune virolysis: effect of antibody and complement on C-type RNA virus. Science 168, 1478–1480 (1970).PubMedGoogle Scholar
  132. Oroszlan, S., Hatanaka, M., Gilden, R. V., Huebner, R. J.: Specific inhibition of mammalian ribonucleic acid C-type virus deoxyribonucleic acid polymerases by rat antisera. J. Virol. 8, 816–818 (1971b).PubMedGoogle Scholar
  133. Oroszlan, S., Huebner, R. J., Gilden, R. V.: Species-specific and interspecies-specific antigenic determinants associated with feline C-type virus structural protein. Proc. nat. Acad. Sci. (Wash.) 68, 901–905 (1971c).Google Scholar
  134. Oroszlan, S., White, M. M. H., Gilden, R. V., Charman, H. P.: A rapid direct radioimmunoassay for type C virus group-specific antigen and antibody. Virology 50, 294–296 (1972).PubMedGoogle Scholar
  135. Parkman, R., Levy, J. A., Ting, R. C.: Murine sarcoma virus: the question of defectiveness. Science 168, 387–389 (1970).PubMedGoogle Scholar
  136. Parks, W. P., Livingston, D. M., Todaro, G. J., Benveniste, R. E., Scolnick, E. M.: Radioimmunoassay of mammalian type C viral proteins. III. Detection of viral antigen in normal murine cells and tissues. J. exp. Med. 137, 622–635 (1973).PubMedGoogle Scholar
  137. Parks, W. P., Scolnick, E. M.: Radioimmunoassay of mammalian type-C viral proteins. II. Interspecies antigenic reactivities of the major internal polypeptide. Proc. nat. Acad. Sci. (Wash.) 69, 1766–1770 (1972).Google Scholar
  138. Payne, L. N., Chubb, R. C.: Studies on the nature and genetic control of an antigen in normal chick embryos which reacts in the COFAL test. J. gen. Virol. 3, 379–391 (1968).PubMedGoogle Scholar
  139. Peebles, P. T., Haapala, D. K., Gazdar, A. F.: Deficiency of viral ribonucleic acid-dependent deoxyribonucleic acid polymerase in noninfectious virus-like particles released from murine sarcoma virus-transformed hamster cells. J. Virol. 9, 488–493 (1972).PubMedGoogle Scholar
  140. Peters, R. L., Hartley, J. W., Spahn, G. J., Rabstein, L. S., Whitmire, C. E., Turner, H. C., Huebner, R. J.: Prevalence of the group-specific (gs) antigen and infectious virus expression of the murine C-type RNA viruses during the life span of BALB/cCr mice. Int. J. Cancer 10, 283 (1972b).PubMedGoogle Scholar
  141. Peters, R. L., Spahn, G. J., Rabstein, L. S., Kelloff, G. J., Huebner, R. J.: Murine C-type RNA virus from spontaneous neoplasms: in vitro host range and oncogenic potential. Science 181, 665–667 (1973).PubMedGoogle Scholar
  142. Peters, R. L., Spahn, G. J., Rabstein, L. S., Turner, H. C., Huebner, R. J.: Incidence of spontaneous neoplasms in breeding and retired breeder BALB/cCr mice throughout the natural life span. Int. J. Cancer 10, 273 (1972a).PubMedGoogle Scholar
  143. Phillips, L. A., Hollis, V. W., Bassin, R. H., Fischinger, P. J.: Characterization of the RNA from noninfectious virions produced by sarcoma positive leukemia negative 3T3 cells. Proc. nat. Acad. Sci. (Wash.) 70, 3002–3007 (1973).Google Scholar
  144. Pincus, T., Hartley, J. W., Rowe, W. P.: A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally-occurring viruses. J. exp. Med. 133, 1219–1233 (1971a).PubMedGoogle Scholar
  145. Pincus, T., Rowe, W. P., Lilly, F.: A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to Friend murine leukemia virus. J. exp. Med. 133, 1234–1241 (1971b).PubMedGoogle Scholar
  146. Rhim, J. S., Demoise, C. F., Duh, F. G., Cho, H. Y.: Transformation of guinea pig embryo cells by a murine sarcoma virus. Virology 48, 841–843 (1972).PubMedGoogle Scholar
  147. Rhim, J. S., Vernon, L., Duh, F. G., Huebner, R. J.: Wide host range of murine sarcoma virus. Int. J. Cancer 12, 734–748 (1973).PubMedGoogle Scholar
  148. Robert, M. S., Smith, R. G., Gallo, R. C.: Viral and cellular DNA polymerase: comparison of activities with synthetic and natural RNA templates. Science 176, 798–800 (1972).PubMedGoogle Scholar
  149. Rowe, W. P.: The kinetics of rescue of the murine sarcoma virus genome from a non-producer line of transformed mouse cells. Virology 46, 369–374 (1971a).PubMedGoogle Scholar
  150. Rowe, W. P.: Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1n strains of mice. J. exp. Med. 136, 1272–1285 (1971b).Google Scholar
  151. Rowe, W. P., Hartley, J. W.: Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv-1b strains of mice. J. exp. Med. 136, 1286–1301 (1972).PubMedGoogle Scholar
  152. Rowe, W. P., Hartley, J. W., Bremner, T.: Genetic mapping of a murine leukemia virus-inducing locus of AKR mice. Science 178, 860–862 (1972).PubMedGoogle Scholar
  153. Rowe, W. P., Hartley, J. W., Capps, W. I.: Tissue culture and serologic studies of mouse leukemia viruses. Nat. Cancer Inst. Monogr. No. 22, 15–19 (1966).PubMedGoogle Scholar
  154. Rowe, W. P., Hartley, J. W., Lander, M. R., Pugh, W. E., Teich, N.: Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus. Virology 46, 866–876 (1971).PubMedGoogle Scholar
  155. Rowe, W. P., Humphrey, J. B., Lilly, F.: A major genetic locus affecting resistance to infection with murine leukemia viruses. III. Assignment of the Fv-1 locus to linkage group VIII of the mouse. J. exp. Med. 137, 850–853 (1973).PubMedGoogle Scholar
  156. Rowe, W. P., Pincus, T.: Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice. J. exp. Med. 135, 429–436 (1972).PubMedGoogle Scholar
  157. Rowe, W. P., Pugh, W. E., Hartley, J. W.: Plaque assay techniques for murine leukemia viruses. Virology 42, 1136–1139 (1970).PubMedGoogle Scholar
  158. Saal, F., Pasqualini, C. D., Rabasa, S. L.: Study of the gross antigen in BALB leukemias and tumors of different origin. Cancer Res. 31, 23–26 (1971).PubMedGoogle Scholar
  159. Sanford, K. K., Handleman, S. L., Hartley, J. W., Jackson, J. L., Gantt, R. R.: “Spontaneous” neoplastic transformation in vitro: influence of endogenous murine leukemia virus and serum fractions. J. nat. Cancer Inst. 49, 1177–1189 (1972).PubMedGoogle Scholar
  160. Sarma, P. S., Cheong, M. P., Hartley, J. W., Huebner, R. J.: A viral interference test for mouse leukemia viruses. Virology 33, 180–184 (1967).PubMedGoogle Scholar
  161. Sarma, P. S., Gazdar, A. F., Turner, H. C., Dejkunchorn, P.: Gazdar strain of murine sarcoma virus. Biologic and antigenic interactions with the heterologous hamster host. Proc. Soc. exp. Biol. (N.Y.) 140, 928–933 (1972).Google Scholar
  162. Sarma, P. S., Huebner, R. J., Basker, J. F., Vernon, L., Gilden, R. V.: Feline leukemia and sarcoma viruses: susceptibility of human cells to infection. Science 29, 1098–1100 (1970a).Google Scholar
  163. Sarma, P. S., Huebner, R. J., Turner, H. C., Gilden, R. V., Log, T.: Feline leukaemia viral antigens and antisera to the group specific antigens of the murine leukaemia viruses. Nature (Lond.) New Biol. 230, 50–52 (1971).Google Scholar
  164. Sarma, P. S., Log, T.: Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology 54, 160–169 (1973).PubMedGoogle Scholar
  165. Sarma, P. S., Log, T., Gazdar, A. F.: Control of group-specific antigen synthesis by the defective Gazdar murine sarcoma virus genome. Virology 52, 568–573 (1973).PubMedGoogle Scholar
  166. Sarma, P. S., Log, T., Huebner, R. J.: Transspecies rescue of defective genomes of murine sarcoma virus from hamster tumor cells with helper feline leukemia virus. Proc. nat. Acad. Sci. (Wash.) 65, 81–87 (1970b).Google Scholar
  167. Schäfer, W., Frank, H., Pister, L.: Vergleich des latent in L-Zellen enthaltenen,Virusmit dem Rauscher-Virus der Mause-Leukämie. Z. Naturforsch. 23b, 1275–1276 (1968).Google Scholar
  168. Schäfer, W., Anderer, F. A., Bauer, H., Pister, L.: Studies of mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen. Virology 38, 387–394 (1969).PubMedGoogle Scholar
  169. Schäfer, W., Fischinger, P. J., Lange, J., Pister, L.: Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology 47, 197–209 (1972a).PubMedGoogle Scholar
  170. Schäfer, W., Lange, J., Fischinger, P. J., Frank, H., Bolognesi, D. P., Pister, L.: Properties of mouse leukemia viruses. II. Isolation of viral components. Virology 47, 210–228 (1972b).PubMedGoogle Scholar
  171. Schäfer, W., Pister, L., Hunsmann, G., Moennig, V.: Comparative serological studies on type C viruses of various mammals. Nature (Lond.) New Biol. 245, 75–77 (1973).Google Scholar
  172. Scolnick, E. M., Parks, W. P.: Host range studies on xenotropic type-C viruses in somatic cell hybrids. Virology, in press (1973).Google Scholar
  173. Scolnick, E. M., Parks, W. P., Livingston, D. M.: Radioimmunoassay of mammalian type C viral proteins. I. Species specific reactions of murine and feline viruses. J. Immunol. 109, 570–577 (1972).PubMedGoogle Scholar
  174. Steeves, R. A., Eckner, R. J., Bennett, M., Mirand, E. A., Trudel, P. J.: Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex J. nat. Cancer Inst. 46, 1209–1217 (1971).PubMedGoogle Scholar
  175. Stephenson, J. R., Aaronson, S. A.: A genetic locus for inducibility of C-type virus in BALB/c cells; the effect of a nonlinked regulatory gene on detection of virus after chemical activation. Proc. nat. Acad. Sci. (Wash.) 69, 2798–2801 (1972a).Google Scholar
  176. Stephenson, J. R., Aaronson, S. A.: Genetic factors influencing C-type RNA virus induction. J. exp. Med. 136, 175–184 (1972b).PubMedGoogle Scholar
  177. Stephenson, J. R., Aaronson, S. A.: Antigenic properties of murine sarcoma virus-transformed BALB/3T3 nonproducer cells. J. exp. Med. 135, 503–515 (1972c).PubMedGoogle Scholar
  178. Stephenson, J. R., Aaronson, S. A.: Expression of endogenous RNA C-type virus group-specific antigens in mammalian cells. J. Virol. 12, 564–569 (1973).PubMedGoogle Scholar
  179. Stockert, E., Old, L. J., Boyse, E. A.: The GIX system. J. exp. Med. 133, 1334–1355 (1971).PubMedGoogle Scholar
  180. Stuck, B., Old, L. J., Boyse, E. A.: Occurrence of soluble antigen in the plasma of mice with virus-induced leukemia. Proc. nat. Acad. Sci. (Wash.) 52, 950–958 (1964).Google Scholar
  181. Taylor, B. A., Meier, H., Huebner, R. J.: Genetic control of the group-specific antigen of murine leukemia virus. Nature (Lond.) New Biol. 241, 184–185 (1973).Google Scholar
  182. Taylor, B. A., Meier, H., Myers, D. D.: Host-gene control of C-type RNA tumor virus: inheritance of the group-specific antigen of murine leukemia virus. Proc. nat. Acad. Sci. (Wash.) 68, 3190–3194 (1971).Google Scholar
  183. Temin, H. M., Mizutani, S.: RNA-dependent DNA polymerase in virion of Rous sarcoma virus. Nature (Lond.) 226, 1211–1213 (1970).Google Scholar
  184. Tennant, J. R., Snell, G. D.: The H-2 locus and viral leukemogenesis as studied in congenic strains of mice. J. nat. Cancer Inst. 41, 597–604 (1968).PubMedGoogle Scholar
  185. Ting, R. C.: In vitro transformation of rat embryo cells by a murine sarcoma virus. Virology 28, 783–785 (1966).PubMedGoogle Scholar
  186. Ting, R. C., Bader, A. V.: A quantitative study on transformation of hamster embryo cells in vitro by murine sarcoma viruses (Harvey and Moloney). Virology 39, 194–204 (1969).PubMedGoogle Scholar
  187. Todaro, G. J.: “Spontaneous” release of type C viruses from clonal lines of “Spontaneously” transformed BALB/3T3 cells. Nature (Lond.) New Biol. 240, 157–160 (1972).Google Scholar
  188. Todaro, G. J.: (1973), Personal communication.Google Scholar
  189. Todaro, G. J., Arnstein, P., Parks, W. P., Lennette, E. H., Huebner, R. J.: A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc. nat. Acad. Sci. (Wash.) 70, 859–862 (1973).Google Scholar
  190. Todaro, G. J., Huebner, R. J.: The viral oncogene hypothesis: new evidence. Proc. nat. Acad. Sci. (Wash.) 69, 1009–1015 (1972).Google Scholar
  191. Vernon, M. L., Lane, W. T., Huebner, R. J.: Prevalence of type C particles in visceral tissues of embryonic and newborn mice. J. nat. Cancer Inst., in press (1973).Google Scholar
  192. Vogt, P. K.: Envelope classification of avian RNA tumor viruses. In: Fourth International Symposium for Comparative Leukemia Research, 1969 (R. M. Dutcher, ed.), p. 153–167, Bibl. haemat. 36. Basel: Karger 1970.Google Scholar
  193. Whitmire, C. E., Salerno, R. A., Rabstein, L. S., Huebner, R. J., Turner, H. C.: RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene. J. nat. Cancer Inst. 47, 1255–1265 (1971).PubMedGoogle Scholar
  194. Wong, P. K. Y., Russ, L. J., McCarter, J. A.: Rapid selective procedure for isolation of spontaneous temperature-sensitive mutants of Moloney leukemia virus. Virology 51, 424–431 (1973).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1974

Authors and Affiliations

  • Padman S. Sarma
  • Adi F. Gazdar
    • 1
  1. 1.National Cancer InstituteNational Institutes of Health BethesdaUSA

Personalised recommendations